**INTRODUCTION:** Lymphedema is a lifelong condition caused by lymphatic system deficiency. Current treatment strategies focus on symptom alleviation rather than functional restoration of lymphatic system failure. In addition, defective lymphatic growth is an important aspect of impaired wound healing. Recently, stem/progenitor cell transplantation has emerged as an approach for lymphatic regeneration, however, it remains undetermined whether this is effective on different anatomical levels of the system.

**MATERIALS AND METHODS:** We used a complement of mouse models to test the potential of mouse and human multipotent adult progenitor cells (MAPCs) for lymphatic growth from the lymphatic capillary to the precollector level.

**RESULTS:** MAPCs differentiated into lymphatic endothelial cells (LECs) and trophically supported LEC proliferation, migration and sprouting in vitro. In vivo, in addition to supporting blood vessel growth, MAPC transplantation significantly induced lymphatic capillary regrowth in wounds and functionally restored lymph drainage across skin flaps by stimulating capillary and precollector vessel growth mostly through paracrine effects.

**CONCLUSIONS:** MAPC transplantation represents a powerful remedy for lymphatic growth at different anatomical levels and hence an appealing approach to treat wounds and lymphedema.
